Get Started
Lung Cancer Curricula
Step 1
These independent CME/CE activities are supported by educational grants from Genentech BioOncology

OSI Oncology



The Advanced Certificate Program in
Lung Cancer Management
  1. Curriculum III
  2. Curriculum II
  3. Curriculum I
  4. Full Course List
Search by


Currently Available

Course Title Curriculum Faculty Release Date
Combining EGFR and Antiangiogenic Agents in NSCLC — Article Review (LC01.24) 1794.12 I Herbst Mar 2008
Case Study: Choosing Specific Treatment Schedules and Agents in Locally Advanced Unresected NSCLC — Tx Reporter e-Newsletter (LC01.23) 1795.06 I Herbst
Choy
Sandler		 Feb 2008
Molecular Analysis Can Improve Therapy Decisions for Advanced Non–Small-Cell Lung Cancer — Article Review (LC01.22) 1794.11 I Brahmer Feb 2008
Case Study: Supportive Care of the Patient Undergoing Antineoplastic Treatment for NSCLC — Tx Reporter e-Newsletter (LC01.21) 1795.05 I Herbst
Langer		 Jan 2008
The Role of Systemic Therapy in PS-2 Advanced NSCLC — Article Review (LC01.19) 1794.10 I Langer Jan 2008
Case Study: Management of Recurrent Metastatic NSCLC—Chronic Treatment with Biologic Agents — Tx Reporter e-Newsletter (LC01.20) 1795.04 I Herbst
Langer		 Jan 2008
Role of Small Molecule Multikinase Inhibitors in NSCLC — Article Review (LC01.18) 1794.09 I Sandler Dec 2007
Emerging Concepts and Controversies in Lung Cancer — Audio Interview (LC01.17) 1797.06 I Herbst
Brahmer		 Dec 2007
Innovative Local Treatment Strategies — Audio Interview (LC01.16) 1797.05 I Langer
Choy
Pass		 Dec 2007
Role of Prophylactic Cranial Irradiation in Preventing Brain Metastasis and Improving Overall Survival in Patients with Extensive Small-Cell Lung Cancer — Article Review (LC01.15) 1794.08 I Choy Nov 2007
Case Study: Staging and Treatment Approaches in Advanced NSCLC — Tx Reporter e-Newsletter (LC01.13) 1795.03 I Langer
Brahmer		 Oct 2007
Treatment of Advanced Bronchioloalveolar Carcinoma (BAC) — Article Review (LC01.14) 1794.07 I Sandler Oct 2007
How to Best Integrate Chemotherapy with RT in Locally Advanced NSCLC — Article Review (LC01.12) 1794.06 I Herbst Sep 2007
What’s New in EGFR and Other Targeted Therapies in NSCLC? — Audio Interview (LC01.11) 1797.04 I Langer
Sandler		 Sep 2007
MET Amplification: A Mechanism Leading to Gefitinib Resistance in NSCLC — Article Review (LC01.10) 1794.05 I Herbst Aug 2007
Case Study: Clinical Staging, Initial Prognosticators, and Treatment Approaches in NSCLC — Tx Reporter e-Newsletter (LC01.09) 1795.02 I Herbst
Sandler
Pass		 Aug 2007
Emerging Chemotherapies and Antiangiogenesis Therapies in NSCLC — Audio Interview (LC01.08) 1797.03 I Herbst
Langer		 Aug 2007
State-of-the-Art Mediastinal Staging with PET — Article Review (LC01.07) 1794.04 I Pass Jul 2007
Case Study: NSCLC Basics—Screening and Detection — Tx Reporter e-Newsletter (LC01.05) 1795.01 I Langer
Pass		 Jul 2007
Confirmation of the Role of Angiogenesis Inhibition in Advanced NSCLC — Article Review (LC01.06) 1794.03 I Sandler Jul 2007
Clinical Staging and Stage-Specific Treatment Approaches to Curable NSCLC — Audio Interview (LC01.04) 1797.02 I Herbst
Choy
Pass		 Jun 2007
The Seesaw Odyssey of Irinotecan in the Therapy of Small-Cell Lung Carcinoma — Article Review (LC01.03) 1794.02 I Langer May 2007
Applying Standard Guidelines to Practice — Audio Interview (LC01.02) 1797.01 I Herbst
Langer		 Apr 2007
What's New in State-of-the-Art Adjuvant Therapy in Resectable (I-IIIA) Lung Cancer? — Article Review (LC01.01) 1794.01 I Brahmer Apr 2007